Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06233812
Other study ID # 23-0413
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date August 1, 2024

Study information

Verified date January 2024
Source Northwell Health
Contact Marcus L Elias, MD
Phone 862-371-6427
Email melias2@northwell.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study hypothesis is that the use of running epidermal sutures in full-thickness skin graft (FTSG) placement for patients undergoing dermatologic surgery (Mohs micrographic surgery or excision) is non-inferior to the use of simple interrupted sutures with respect to cosmetic outcome. This will be a split-scar (within-person) study, in which half of each participant's scar will receive the study intervention (running epidermal sutures), with the other half receiving the control intervention (simple interrupted sutures). The primary outcome, total observer score of the Patient and Observer Scar Assessment Scale (POSAS) 2.0, will be assessed by two blinded observers at a 3-month follow-up visit, and compared between scar halves.


Description:

A FTSG is used in lieu of linear repair or local tissue skin flap rearrangement when surrounding skin tissue laxity is unavailable or the patient prefers a graft instead. Typically the skin for a FTSG is harvested from a local or distant donor site depending on skin tissue match and tissue availability and sutured into place. The site where the FTSG was taken is primarily repaired or allowed to heal via second intent. This study is important because it provides a comparison of cosmetic outcome between interrupted versus running cutaneous sutures. The information provided would help determine if a more efficient suturing technique is non-inferior to a less efficient one, thus saving time for the patient and provider. There is no current standard of practice, with dermatologic surgeons using both interrupted and running sutures, as there is a paucity of literature on this topic as related to full thickness grafts after dermatologic surgery. Running epidermal sutures are more time efficient and thus decrease patient intra-operative time, save on suture material, increase surgeon productivity, and may improve the overall patient operative experience. There have been multiple other split scar studies and studies related to the cosmetic outcomes of various suturing practices. However, there have been none that have looked at simple versus running epidermal stitching of FTSG placement.


Recruitment information / eligibility

Status Recruiting
Enrollment 52
Est. completion date August 1, 2024
Est. primary completion date August 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Inclusion criteria will capture patients - 18 years or older - have a FTSG reconstruction - any body site - to close to a primary defect after dermatologic surgery. The authors will exclude patients not undergoing reconstruction with full-thickness skin-graft placement, unable to return for follow-up visits, unable to provide consent (eg. unable to understand spoken/written English, mentally handicapped), and patients under 18 years of age. Male and female patients are eligible. Planned enrollment based on a priori sample size calculation is 52 patients. Exclusion Criteria: - Not undergoing reconstruction with full-thickness skin-graft placement - FTSG not large enough to accommodate at least 3 interrupted sutures on one half side - Pregnancy or lactation - Under 18 years of age - Unable/unwilling to return for follow-up visits - Unable to provide consent (eg. unable to understand spoken/written English, mentally handicapped)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Simple interrupted suturing technique
Both simple interrupted and running epidermal sutures are considered acceptable, appropriate techniques for FTSG placement. Therefore, this study would be important in determining whether running sutures, the more efficient method, are non-inferior to simple interrupted sutures.
Running suturing technique
Both simple interrupted and running epidermal sutures are considered acceptable, appropriate techniques for FTSG placement. Therefore, this study would be important in determining whether running sutures, the more efficient method, are non-inferior to simple interrupted sutures.

Locations

Country Name City State
United States Marcus Elias N. New Hyde Park New York

Sponsors (1)

Lead Sponsor Collaborator
Northwell Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Patient and Observer Scar Assessment Scale (POSAS) Total observer score of the Patient and Observer Scar Assessment Scale (POSAS) 2.0
The patient score combines scar pain, itch, color, stiffness, thickness, and irregularity (1-10). The observer scale comprises of the items vascularity, pigmentation, thickness, relief, pliability, and surface area. All items of the patient and observer score combined will form a total POSAS score (the highest score represents the worst scar imaginable). It also consists of an overall opinion of the scar
POSAS 2.0 observer total score at 3 months post-surgery, calculated as the average of two observers' total scores.
Secondary Clinician overall opinion Clinician observer overall opinion of scar quality, measured on a 10-point scale (1-10) by two observers and averaged through study completion, an average of 1 year
Secondary Patient overall opinion Patient overall opinion of scar quality, measured on a 10-point scale (1-10) through study completion, an average of 1 year
Secondary Complications Number of patients experiencing bleeding requiring physician intervention after surgery Number of patients experiencing graft failure Number of patients developing infection between date of surgery and 3-month follow-up visit Number of patients with hypertrophic or keloidal scar formation Number of patients experiencing wound dehiscence (re-opening) between surgery and the 3-month follow-up visit through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04997863 - Clinical Efficacy and Safety of Sericin Hydrogel Sheet Impregnated With Bird's Nest Extract N/A
Completed NCT05335720 - Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site) N/A
Active, not recruiting NCT04456127 - CO2 Laser Revision for Burn Related Donor Site Scars N/A
Recruiting NCT05447793 - Effectiveness and Tolerability of Fitostimoline Plus vs Connettivina Bio Plus in Skin Graft
Recruiting NCT04186273 - Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. Phase 2
Completed NCT04176705 - Fractional Ablative Laser Treatment for Skin Grafts N/A
Completed NCT06044519 - A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting. Phase 4